Evidence map›Paper›PMID 20829399›Full record

ArticleJournal of medical microbiology2011

A report of Streptococcus pneumoniae serotype 6D in Europe.

M H Nahm, M B Oliver, L Siira, T Kaijalainen, L M Lambertsen, A Virolainen

Abstract read
In one paragraph

Article in Journal of medical microbiology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Genome sequences of 36Microbiology resource announcements · 2024
    Article
  2. Article
  3. Article
  4. Observational
  5. Article
  6. Article
  7. Review
  8. Article
  9. Novel pneumococcal serotypes 6C and 6D: anomaly or harbinger.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2012
    Review
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

M H NahmUniversity of Alabama at Birmingham, Birmingham, AL, USA.
M B OliverUniversity of Alabama at Birmingham, Birmingham, AL, USA.
L SiiraNational Institute for Health and Welfare, Helsinki, Finland.
T KaijalainenNational Institute for Health and Welfare, Oulu, Finland.
L M LambertsenStatens Serum Institute, Copenhagen, Denmark.
A VirolainenNational Institute for Health and Welfare, Helsinki, Finland.

Funding

Impact of a new group 6 serotype on pneumococcal vaccinesR01AI031473 · NIAID · WASHINGTON UNIVERSITY · PI NAHM, MOON H. · 1991 to 2011
$1.7M
Pneumococcal capsule and host innate immunityR56AI031473 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI NAHM, MOON H. · 2012 to 2012
$366k
NIAID NIH HHS AI-31473NIAID NIH HHS R01 AI031473NIAID NIH HHS R56 AI031473
6 · The paper itself

Abstract

Serotype 6D of Streptococcus pneumoniae has been reported in Asia and the Fijian islands among nasopharyngeal carriage isolates. We now report a 6D isolate from a Finnish adult with invasive pneumococcal disease. Interestingly, the Finnish isolate and Asian isolate capsule gene loci are almost identical.

Indexed as

AdultAgedBacterial Typing TechniquesDNA, BacterialFemaleFinlandHumansMolecular Sequence DataPneumococcal InfectionsSequence Analysis, DNASequence Homology, Nucleic AcidSerotypingStreptococcus pneumoniaeDNA, Bacterial

Identifiers

PMID20829399
PMCPMC3052471

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.